Cellebrite DI (CLBT) Other Non-Current Liabilities (2021 - 2025)

Cellebrite DI's Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $16.7 million for Q4 2025.

• On a quarterly basis, Other Non-Current Liabilities rose 139.82% year-over-year to $16.7 million in Q4 2025; TTM through Dec 2025 was $16.7 million, a 139.82% increase from a year earlier, with the FY2025 full-year figure at $16.7 million, up 139.82% from the prior year.
• Other Non-Current Liabilities climbed to $16.7 million in Q4 2025 per CLBT's latest filing, from $7.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $56.5 million in Q4 2021 and bottomed at $5.0 million in Q2 2023.
• The 5-year median for Other Non-Current Liabilities is $6.6 million (2022), against an average of $12.4 million.
• Across the five-year window, Other Non-Current Liabilities tumbled 90.45% in 2022 and jumped 903.28% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $56.5 million in 2021, then tumbled by 90.45% to $5.4 million in 2022, then soared by 903.28% to $54.1 million in 2023, then slumped by 87.15% to $7.0 million in 2024, then surged by 139.82% to $16.7 million in 2025.
• Per Business Quant, the three latest CLBT Other Non-Current Liabilities figures stand at $16.7 million (Q4 2025), $7.5 million (Q3 2025), and $6.9 million (Q2 2025).